This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Cheng-Kung University. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Kao-Shu Chuang: Innovator in Nucleic Acid Cleavage Technology
Introduction
Kao-Shu Chuang is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of gene therapy and nucleic acid technology. His innovative work has led to the development of a unique nucleic acid cleavage kit, which has potential applications in various scientific and medical fields.
Latest Patents
Kao-Shu Chuang holds a patent for a "Cleavage kit, and gene therapy by using the same and nucleic acid cleavage detection apparatus." This nucleic acid cleavage kit is designed to cleave a target nucleic acid. The kit includes a carrier, an oligonucleotide, and a nucleic acid cleavage agent. The oligonucleotide is capable of recognizing at least a partial sequence of the target nucleic acid. Subsequently, the nucleic acid cleavage agent cleaves the target nucleic acid. Additionally, the patent discloses a nucleic acid cleavage detection apparatus that incorporates the nucleic acid cleaving kit and outlines a gene therapy method utilizing the kit.
Career Highlights
Kao-Shu Chuang is affiliated with National Cheng-Kung University, where he continues to advance his research and innovation in the field of nucleic acids. His work has garnered attention for its potential to enhance gene therapy techniques and improve medical outcomes.
Collaborations
Kao-Shu Chuang has collaborated with notable colleagues, including Wu-chou Su and Jih-Ru Hwu. These partnerships have contributed to the development and refinement of his innovative technologies.
Conclusion
Kao-Shu Chuang is a distinguished inventor whose work in nucleic acid cleavage technology is paving the way for advancements in gene therapy. His contributions are significant in the scientific community and hold promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile